Biotech and Pharmaceuticals Medicine

  • U.S. regulators dealt a major blow to Novo Nordisk's hopes for its new long-acting insulin Tresiba by demanding the Danish drugmaker conduct additional clinical tests to assess potential heart risks.

  • A man is given a flu shot by at the medical offices of Yaffe Ruden & Associates in New York.

    Flu season is drawing attention to mandatory paid sick leave for the 40 percent of American private-sector workers — more than 40 million people — who don't have it.

  • Fighting the Flu-demic

    New data from the CDC shows doctor visits related to the flu continued to decline last week. Robert Kelly, president of New York Presbyterian Hospital, weighs in.

  • Flu Outbreak 2013

    This flu season is striking early, but is it really an epidemic? Tevi Troy, Romney Health Care Policy adviser, weighs in.

  • pills.jpg

    The big U.S. and European drug companies are dealing with their own 'cliff' as blockbuster drugs lose their patent protection. But they are turning back to research and development to fill the gap.

  • medicare.jpg

    Making the health care system function better could save $2 trillion on health costs over the next decade, Dr. David Blumenthal, Commonwealth Fund president, told CNBC on Friday.

  • Flu Reaches Epidemic Level in U.S.

    Widespread influenza activity has afflicted 47 states, according to the CDC. Phil Hosbach, VP of Immunization Policy, discusses whether people should be worried about dwindling supplies.

  • Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.

  • 'Rare Good News' on Health Care Retirement Savings: Study

    Rock bottom interest rates will likely boost key stocks in the biotechnology sector, but Obamacare will dampen prospects for HMO shares.

  • Health Premiums Skyrocket

    Peter Suderman, Reason Magazine, explains whether insurance company premiums are rising under so-called Obamacare. Meanwhile Michael Farr, Farr, Miller & Washington, discusses what that means for health stocks.

  • doctor-and-xrays-140.jpg

    The Affordable Care Act will go far to rescue the generation hardest hit by rising health-care costs, including 8.6 million Boomers without health insurance.

  • Device Makers Face Excise Tax

    States are setting up health insurance exchanges, reports CNBC's Bertha Coombs. Max Nisen, Business Insider, also weighs in.

  • Ohio, Wisconsin Reject Obamacare Health Exchanges

    It's hard to see how lawmakers can avoid touching health insurance if they want to eliminate loopholes and curtail deductions so as to raise revenue and lower tax rates.

  • Health Care's Own 'Fiscal Cliff'

    Toby Cosgrove, CEO & president at The Cleveland Clinic, explains how "fiscal cliff" cuts could severely impact the health care industry.

  • Bring Health Care Costs Down Through Innovation

    Health care costs, especially in drug development remains high despite advancements in medicine. But as Taher Abbasi, CEO of Cellworks tells CNBC's Martin Soong, that is all set to change with innovation.

  • Sanofi: Moving Outside of the BRICS

    Christopher Viehbacher, CEO, Sanofi says that as cost rises, the firm is growing its emerging-markets business outside of the BRIC nations.

  • Merck Profit Beats Forecasts, Keeps 2012 Sales Outlook

    Merck reported higher-than-expected quarterly results on Friday and said it continued to expect full-year revenue to be at or near 2011 levels on a constant currency basis.

  • Health Care Needs More Entrepreneurs and Innovation: Google Ventures Head

    The managing partner of Google's venture capital, Bill Maris,  says under-investment in health sciences is short-sighted.

  • DNA

    The goal is to enable physicians and pharmaceutical companies to use complex genetic data to tailor treatment on an individual basis, according to Mike Pellini, CEO of Foundation Medical.

  • Paul_E._Jacobs-200.jpg

    Qualcomm's CEO Paul Jacobs says the smart phone will become a focal point for wirelessly connecting medical devices, diagnostics and sensors, and providing near real-time information.